Georges Pompidou Hospital
Paris, 75015, France
NCT Number: NCT01252992
Tuberculous paradoxical reactions (PR) are immune reactions occurring during the course of antituberculous treatment and leading to a worsening of tuberculous symptoms after an initial improvement. This phenomenon has very extensively studied in HIV infected patients where it corresponds to the so called IRIS (immune reconstitution syndrome). However, it laso occurs in non immuno-compromized patients, especially those with extra-pulmonary localization of tuberculosis. The aim of the study is to look for risk factors of paradoxical reaction in non immuno-compromized patients with extra-pulmonary tuberculosis. The investigators will consider clinical, radiological and biological variables, including specific immune and genetic markers. Our secondary goals are to estimate the incidence of PR, describe their natural history; characterize the type of immune response they correspond to, and look for better diagnostic tools.The immunological characterization and the finding of predictive factors of PR, especially the genetic ones will allow a better understanding of biological mechanisms that lead to their occurrence during extra-pulmonary tuberculosis treatment. The establishment of predictive criteria could permit a better surveillance of at risk patients for a rapid treatment, or even a prevention of PR. The establishment of new diagnostic criteria at the time of PR could avoid numerous invasive diagnostic procedures, surgery and/or useless prolongation of antibiotic treatment.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Paris, 75015, France
Primary objective :
Search for predictive factors of tuberculous paradoxical reaction (PR), with assessment of clinical, radiological and biological factors.
Secondary objectives :
Inclusion Status of patients (determined by a validation comity at M6)
Primary outcome :
Secondary outcomes :
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
One supplementary ACD tube of 5 ml à D0, D15, M2, PR+, for RNA extraction.
at day 0, Month 2, paradoxical reaction, end of treatment, read by an independent radiologist
For patients included until 20 PR+ : blood puncture of 4 ACD tubes of 10 ml, 1 EDTA tube of 7,5 ml et 1 heparinate lithium tube of 7,5ml at D0, D15, M2, and M6 and at the time of an potential RP+
at M0, M2, M6 and in case of PR+.
Time frame: at 6 months
Risk factors of paradoxical reaction : clinical, radiological immune and genetic factors
Time frame: during the first 6 months
Time frame: during the first 6 months
Time frame: during the first 6 months
Assistance Publique - Hôpitaux de Paris
Other
Paradoxical Reactions During Anti-mycobacterial Treatment of Extrapulmonary Tuberculosis in Non Immuno-compromized Patients : Clinical, Radiological et Immunological
Acronym: PARATB
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04122404
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
Accra, Ghana
View Trial DetailsNCT01613196
Actinomycetales Infections, Bacterial Infections
Paris, France
View Trial DetailsNCT06875336
Actinomycetales Infections, Bacterial Infections
Bonn, Germany
View Trial DetailsNCT02729532
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
Lusaka, Zambia
View Trial Details